OrbiMed Advisors
hybrid fundWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
Named as a VC funding rare-disease startups; the project's drug-repurposing and mechanism-of-action capabilities could support rare-disease therapeutic development.